Authors
Latest:
Marketing During the COVID-19 CrisisAn overview of marketing during the COVID-19 crisis and how to utilize various tactical solutions to successfully reach your targeted healthcare professional audiences.
Latest:
The New Age of BioDigital PharmaIt’s no longer sufficient for a pharma to develop better products or even build simple apps. The industry increasingly needs to create sophisticated predictive algorithms to maximize the ability of its products, write Tom Agan and Fred Geyer.
Latest:
Episode 28: Digital MedicineMichelle Maskaly and Christen Harm speak with Bill Carson, President & CEO of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Kabir Nath, President & CEO of Otsuka North America Pharmaceuticals about digital medicine, mental health therapies, and creating a smooth and collaborative relationship between R&D and commercial.
Latest:
Launch for Long-Term SuccessStudy examines why a pharma brand’s early sales are not a trusted predictor for total lifetime value-it’s about driving waves of growth.
Latest:
Launch for Long-Term SuccessStudy examines why a pharma brand’s early sales are not a trusted predictor for total lifetime value-it’s about driving waves of growth.
Latest:
Launch for Long-Term SuccessStudy examines why a pharma brand’s early sales are not a trusted predictor for total lifetime value-it’s about driving waves of growth.
Latest:
Launch for Long-Term SuccessStudy examines why a pharma brand’s early sales are not a trusted predictor for total lifetime value-it’s about driving waves of growth.
Latest:
Portfolio Management Health CheckFor pharma, diagnosing what ails or strengthens performance in this critical corporate discipline may help reshape business prognosis.
Latest:
Episode 59: Using Tau to Target Alzheimer’sJanice Kranz, co-founder of Eikonizo Therapeutics, bring us up to date on how targeting tau to fight Alzheimer’s and other neurodegenerative diseases is making waves in the CNS space.
Latest:
Data Curation: The Lifeblood of Organizational EfficiencyThis year, data curation will become as important as document authoring and sit at the core of companies that are nimbly adjusting to an ever-changing marketplace, writes John Lawrie.
Latest:
AI-based Social Listening as Aid to PharmacovigilanceHow artificial intelligence can help pharma filter out the online noise when monitoring for safety signals on the web.
Latest:
Pharma Companies Can Solve the Social Media Adverse Events Reporting Problem and Stop WorryingOrganizations can now confidently leverage social media and messaging platforms to market and share content, writes Dawn Lacallade.
Latest:
Meaningful Insights with Graph TechnologyEmil Eifrem examines how life science researchers can uncover new insights using the in-built power of graph technology.
Latest:
What's Behind the Clinical Innovation Gap?In terms of important clinical benefits and outcomes, modern biotech products have rarely shown the advantages of older generations of drugs, writes Bagrat Lalayan.
Latest:
Real-World Data Networks: Automating & Reducing the Burden of Clinical Studies and RegistriesMon, Aug 8, 2022 1:00pm EST | 10:00am PST | 7:00pm CEST Real-world data networks are changing how data is collected and leveraged for evidence generation. A tech-enabled platform approach can significantly automate and reduce the burden of clinical study programs and registries, improve site and patient engagement and lower costs.
Latest:
Reinventing the Role of Medical AffairsAs digital technologies transform drug development and marketing, a retooled medical affairs function can be a competitive differentiator.
Latest:
Upward Mobility: Optimizing Your Pharma T-ProfileWith lessons and perspectives from the field, the importance of harnessing the right combination of skills to advance up and across career ladders is explored.
